Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amino acid supplement-UConn Health is a specialized dietary supplement formulation developed by researchers at UConn Health for the management of nutritional deficiencies in patients with Parkinson's disease. The supplement is specifically engineered to provide essential amino acids while minimizing the competitive inhibition of levodopa (L-Dopa) transport. In Parkinson's disease, standard dietary proteins can interfere with the absorption and blood-brain barrier penetration of L-Dopa because both the drug and large neutral amino acids (LNAAs) utilize the same transport mechanism, the large neutral amino acid transporter 1 (LAT1). This targeted supplement aims to provide necessary protein-building blocks without the 'off-period' motor complications often associated with standard protein intake, thereby supporting both nutritional health and the efficacy of dopamine replacement therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acid supplement-UConn Health.